2-chloro-n(6)cyclopentyladenosine has been researched along with concanavalin a in 1 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (concanavalin a) | Trials (concanavalin a) | Recent Studies (post-2010) (concanavalin a) |
---|---|---|---|---|---|
252 | 0 | 43 | 17,959 | 82 | 1,337 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaimovitz, C; Douvdevani, A; Naamani, O | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and concanavalin a
Article | Year |
---|---|
Pharmacological preconditioning with adenosine A(1) receptor agonist suppresses cellular immune response by an A(2A) receptor dependent mechanism.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; CD3 Complex; Cell Proliferation; Concanavalin A; Cytokines; Leukocytes; Lymphocyte Culture Test, Mixed; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mitogens; Receptor, Adenosine A1; Receptor, Adenosine A2A; Spleen; T-Lymphocytes | 2014 |